EST
EXAS

EA Series Trust’s Exact Sciences EXAS Stock Holding History

EA Series Trust’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$914K Buy
+9,738
New +$760K 0.03% 630

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

EA Series Trust's EXAS Position: Q2 2023 in Review

EA Series Trust opened a new position in Exact Sciences (EXAS) in Q2 2023: 9,738 shares worth $914K. The stake represents 0.03% of the portfolio and ranks #630 among its holdings.

652 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • EA Series Trust held 9,738 shares of Exact Sciences worth $914K as of Q2 2023.
  • Exact Sciences was a new EA Series Trust position in Q2 2023.
  • Exact Sciences made up 0.03% of EA Series Trust's portfolio in Q2 2023, its #630 holding.
  • 652 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.